Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2011-07-19
2011-07-19
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C514S243000
Reexamination Certificate
active
07982033
ABSTRACT:
The invention provides compounds of formula Iand pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB, TrkC or Flt-3 thereby making them useful as anticancer agents.
REFERENCES:
patent: 6670357 (2003-12-01), Leftheris et al.
patent: 6951859 (2005-10-01), Bhide et al.
patent: 6982265 (2006-01-01), Hunt et al.
patent: 7160883 (2007-01-01), Dyckman et al.
patent: 7531539 (2009-05-01), Fink et al.
patent: 7605160 (2009-10-01), Fink et al.
patent: 2008/0045496 (2008-02-01), Fink et al.
patent: 2008/0058337 (2008-03-01), Fink et al.
patent: WO 00/71129 (2000-11-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 03/090912 (2003-11-01), None
patent: WO 2004/013145 (2004-02-01), None
patent: WO 2008/131050 (2008-10-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Freshney et al.,Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p4.
Dermer et al., Bio/Technology, 1994, 12:320.
Powell et al., British Journal of Dermatology, 141: 802-810, 1999.
Cohen et al., Current Opinion in Chemical Biology, 3,459-465, 1999.
Golub et al., Science, 286, 531-537, 1999.
Mass, R. D., Int. J. Radiation Oncology Bio. Phys.vol. 58(3): 932-940, 2004.
Fabbro et al. Pharmacology & Therapeutics 93, 79-98, 2002.
Chen Ping
Fink Brian E.
Balasubramanian Venkataraman
Bristol--Myers Squibb Company
Korsen Elliott
LandOfFree
Pyrrolotriazine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolotriazine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolotriazine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660405